Dr. Robert Ernest Swaney III, FACP, MD, MSPH

Dr. Swaney practices at Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana.

Dr. Swaney's NPI, 1003015207, was assigned on July 17, 2007. Dr. Swaney graduated from University of Michigan Medical School in 1989. Dr. Swaney holds Indiana license 01089229A.

Dr. Swaney's primary practice is Deaconess Midtown Hospital - Outpatient Therapy, at 600 Mary St, Evansville, IN 47747. The practice phone is (812) 450-3324.

Dr. Swaney's primary practice is Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana. Dr. Swaney is also affiliated with Deaconess Midtown Hospital. The medical group on file is Fairfield Memorial Hospital - Horizon Healthcare. Dmand AI also links Dr. Swaney to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swaney practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Swaney's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Swaney is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Swaney's licenses on file in 2 states: Indiana and Colorado.

CMS data shows 1,743 Medicare services from Dr. Swaney across 17 procedure codes in 2024, for 250 Medicare patients. Medicare paid $54,455 for them.

CMS counts 250 Medicare patients who saw Dr. Swaney in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swaney's median patient age at 73, with 53% women.

In 2024, Dr. Swaney wrote 537 Medicare Part D claims for 129 patients. 82% of them were for generic drugs. CMS names the drug for 360 of them, across 15 drugs with 11 or more claims each, at $538,807 in total drug cost. In 2023, CMS named 354 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Swaney for performance year 2024, reported as part of a group. Dr. Swaney accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Swaney, published from 2023 to 2024. Dr. Swaney's most frequent co-authors are Vandana Gupta Abramson, MD, Carlos L. Arteaga, MD and David F. Cella, PhD.

Dmand AI links Dr. Swaney to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 24 general payments to Dr. Swaney from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 89% of the total. Janssen Pharmaceuticals, Inc paid the most, $137.

Dr. Swaney graduated from University of Michigan Medical School in 1989.